Sherlock S
Department of Surgery, Royal Free Hospital School of Medicine, London, UK.
Vaccine. 1990 Mar;8 Suppl:S6-9; discussion S21-3. doi: 10.1016/0264-410x(90)90206-2.
Hepatitis B virus (HBV) is carried by approximately 300 million people in the world. The natural history of the disease in an individual patient depends on the method by which the infection was acquired, whether perinatal, in childhood, as a result of drug abuse, or in the course of health care work. Other important factors determining the course of the disease include an individual's sex and immunological status. Geographic factors also contribute. Changing lifestyles and the use of prophylactic hepatitis B vaccination affect the prevalence in various groups in the community. The clinical course of the disease, possible complications, and a recent classification system for chronic HBsAg carriers are discussed.
全球约有3亿人携带乙肝病毒(HBV)。个体患者疾病的自然史取决于感染的获得方式,无论是围产期、儿童期、因药物滥用还是在医疗保健工作过程中感染。决定疾病进程的其他重要因素包括个体的性别和免疫状态。地理因素也有影响。生活方式的改变和乙肝预防性疫苗接种的使用影响着社区中不同群体的患病率。本文讨论了该疾病的临床进程、可能的并发症以及慢性HBsAg携带者的最新分类系统。